Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Sylvatica Biotech, Inc. in September, 2021 for $587,829.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HD089832-02 | Phase II | 587,829 | September 21, 2021 | |||||||
A SBIR Phase II contract was awarded to Sylvatica Biotech, Inc. in August, 2019 for $655,915.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA228758-02A1 | Phase II | 655,915 | August 8, 2019 | |||||||
A SBIR Phase II contract was awarded to Sylvatica Biotech, Inc. in July, 2018 for $1,519,851.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI124835-02 | Phase II | 1,519,851 | July 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Sylvatica Biotech, Inc. in April, 2019 for $428,799.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 9R44AI145782-02 | Phase II | 428,799 | April 8, 2019 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in August, 2019 for $248,680.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK117801-01A1 | Phase I | 248,680 | August 5, 2019 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in September, 2018 for $284,002.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK119043-01A1 | Phase I | 284,002 | September 4, 2018 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in September, 2019 for $278,617.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK124053-01 | Phase I | 278,617 | September 13, 2019 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in September, 2018 for $219,084.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK120303-01 | Phase I | 219,084 | September 14, 2018 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in September, 2019 for $231,940.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL145934-01 | Phase I | 231,940 | September 24, 2019 | |||||||
A SBIR Phase II contract was awarded to Sylvatica Biotech, Inc. in September, 2022 for $705,323.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DK124053-02 | Phase II | 705,323 | September 26, 2022 | |||||||
A SBIR Phase II contract was awarded to Sylvatica Biotech, Inc. in September, 2016 for $1,000,000.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | W81XWH-16-C-0067 | Phase II | 1,000,000 | September 29, 2016 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in September, 2016 for $275,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD089832-01 | Phase I | 275,000 | September 26, 2016 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in April, 2016 for $274,998.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI124835-01 | Phase I | 274,998 | April 15, 2016 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in September, 2016 for $150,000.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-16-C-0057 | Phase I | 150,000 | September 28, 2016 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in April, 2017 for $224,347.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK113537-01 | Phase I | 224,347 | April 13, 2017 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in February, 2017 for $100,000.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-17-C-0025 | Phase I | 100,000 | February 27, 2017 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in September, 2017 for $285,084.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD090888-01A1 | Phase I | 285,084 | September 21, 2017 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in August, 2016 for $223,529.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM119918-01 | Phase I | 223,529 | August 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Sylvatica Biotech, Inc. in September, 2015 for $150,000.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-15-C-0190 | Phase I | 150,000 | September 30, 2015 |